Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

A new player in the game: epithelial cathepsin S in early cystic fibrosis lung disease.

Mall MA, Schultz C.

Am J Respir Crit Care Med. 2014 Jul 15;190(2):126-7. doi: 10.1164/rccm.201405-0935ED. No abstract available.

PMID:
25025349
2.

miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production.

Weldon S, McNally P, McAuley DF, Oglesby IK, Wohlford-Lenane CL, Bartlett JA, Scott CJ, McElvaney NG, Greene CM, McCray PB Jr, Taggart CC.

Am J Respir Crit Care Med. 2014 Jul 15;190(2):165-74. doi: 10.1164/rccm.201311-1986OC.

3.

Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins.

Taggart CC, Greene CM, Smith SG, Levine RL, McCray PB Jr, O'Neill S, McElvaney NG.

J Immunol. 2003 Jul 15;171(2):931-7.

4.

Overexpression of cathepsin K in mice decreases collagen deposition and lung resistance in response to bleomycin-induced pulmonary fibrosis.

Srivastava M, Steinwede K, Kiviranta R, Morko J, Hoymann HG, Länger F, Buhling F, Welte T, Maus UA.

Respir Res. 2008 Jul 18;9:54. doi: 10.1186/1465-9921-9-54.

5.

Haemophilus influenzae forms biofilms on airway epithelia: implications in cystic fibrosis.

Starner TD, Zhang N, Kim G, Apicella MA, McCray PB Jr.

Am J Respir Crit Care Med. 2006 Jul 15;174(2):213-20. Epub 2006 May 4.

6.

Altered terminal glycosylation and the pathophysiology of CF lung disease.

Rhim AD, Stoykova LI, Trindade AJ, Glick MC, Scanlin TF.

J Cyst Fibros. 2004 Aug;3 Suppl 2:95-6.

7.

Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.

Oglesby IK, Chotirmall SH, McElvaney NG, Greene CM.

J Immunol. 2013 Apr 1;190(7):3354-62. doi: 10.4049/jimmunol.1202960. Epub 2013 Feb 22.

8.

Secretory leucocyte protease inhibitor inhibits interferon-gamma-induced cathepsin S expression.

Geraghty P, Greene CM, O'Mahony M, O'Neill SJ, Taggart CC, McElvaney NG.

J Biol Chem. 2007 Nov 16;282(46):33389-95. Epub 2007 Sep 18.

9.

Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis.

Döring G, Frank F, Boudier C, Herbert S, Fleischer B, Bellon G.

J Immunol. 1995 May 1;154(9):4842-50.

PMID:
7722333
10.

The significance of cathepsins, thrombin and aminopeptidase in diffuse interstitial lung diseases.

Kimura M, Tani K, Miyata J, Sato K, Hayashi A, Otsuka S, Urata T, Sone S.

J Med Invest. 2005 Feb;52(1-2):93-100.

11.

TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells.

Greene CM, Carroll TP, Smith SG, Taggart CC, Devaney J, Griffin S, O'neill SJ, McElvaney NG.

J Immunol. 2005 Feb 1;174(3):1638-46.

12.

High concentrations of pepsin in bronchoalveolar lavage fluid from children with cystic fibrosis are associated with high interleukin-8 concentrations.

McNally P, Ervine E, Shields MD, Dimitrov BD, El Nazir B, Taggart CC, Greene CM, McElvaney NG, Greally P.

Thorax. 2011 Feb;66(2):140-3. doi: 10.1136/thx.2009.130914. Epub 2010 Dec 15.

PMID:
21160087
13.

Identifying the origins of cystic fibrosis lung disease.

Davis SD, Ferkol T.

N Engl J Med. 2013 May 23;368(21):2026-8. No abstract available.

PMID:
23692172
14.

[Clara cell secretion protein].

Luo ZQ, Yue SJ, Zhao BH.

Sheng Li Ke Xue Jin Zhan. 2003 Jul;34(3):227-30. Review. Chinese. No abstract available.

PMID:
14628468
15.

Hyperinflammation in airways of cystic fibrosis patients: what's new?

Jacquot J, Tabary O, Clement A.

Expert Rev Mol Diagn. 2008 Jul;8(4):359-63. doi: 10.1586/14737159.8.4.359. Review. No abstract available.

PMID:
18598217
16.

Mechanisms and markers of airway inflammation in cystic fibrosis.

De Rose V.

Eur Respir J. 2002 Feb;19(2):333-40. Review.

17.

miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression.

Oglesby IK, Bray IM, Chotirmall SH, Stallings RL, O'Neill SJ, McElvaney NG, Greene CM.

J Immunol. 2010 Feb 15;184(4):1702-9. doi: 10.4049/jimmunol.0902669. Epub 2010 Jan 18.

18.

Risk factors for bronchiectasis in children with cystic fibrosis.

Sly PD, Gangell CL, Chen L, Ware RS, Ranganathan S, Mott LS, Murray CP, Stick SM; AREST CF Investigators..

N Engl J Med. 2013 May 23;368(21):1963-70.

19.
20.

Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis.

Gutierrez JP, Grimwood K, Armstrong DS, Carlin JB, Carzino R, Olinsky A, Robertson CF, Phelan PD.

Eur Respir J. 2001 Feb;17(2):281-6.

Supplemental Content

Support Center